optimising lactation for healthy productivity€¦ · re-bred not re-bred modern cows can lactate...
TRANSCRIPT
Optimising Lactation for Healthy Productivity
Chris Knight [email protected] www.foodanimalbiosciences.org
• Optimising Mammogenesis • Obesity, BST
• Optimising Lactogenesis • Angiogenesis, AQP,
• Optimising Milk Yield • rBST
• Optimising Persistency • Extended Lactation
• Optimising Animal Health • bST and cow health
• How are you, cow?
Optimising Mammogenesis
Birth
Puberty
Conception
Pregnancy
Parturition
• LWG prior to puberty is inversely related to eventual milk yield
• This is via an effect on mammary growth
• The effect appears to be permanent
• The effect is mediated through GH, IGF1 and IGF-BP3
The obesity issue
Young lean
Lact d1 lean
Young ob/ob
Lact d1 ob/ob
Problem?
Optimising Mammogenesis
Birth
Puberty
Conception
Pregnancy
Parturition
What about trying to stimulate gestational
mammogenesis?
Is it possible to increase mammary growth using BST?
Stelwagen et al (1992) and (1993)
• Bottom line: No convincing evidence of effect
• Mammogenesis is probably optimal in modern dairy cows
• Observation of postpartum apoptosis supports this
Targets for Optimising Lactation
• Optimising Mammogenesis • Obesity, BST
• Optimising Lactogenesis • Angiogenesis, AQP
• Optimising Milk Yield • rBST
• Optimising Persistency • Extended Lactation
• Optimising Milk Quality • Healthy Milks
• Optimising Animal Health • bST and cow health
• How are you, cow?
Lactogenesis: Questions to Consider
Sudden very large increase in blood flow
and nutrient use.
How? Where does glucose come from?
Why does it suddenly go to the mammary gland?
GLUTs and energy partitioning
Chylomicrons Lymph
Chylomicrons Blood
Dietary Fat
Capillary LPL inactivated
Fat cell
NEB: TG > FFA
Glucose low
Lactating animal
Chylomicrons (TG) Lymph
Chylomicrons (TG) Blood
Dietary Fat
Adipose LPL inactivated
NEB: TG > FFA
Low I
Glucose used by MG
Lactating animal
FFA adipose venous blood
FFA MG capillary
MG FFA + G > TG
TG adipose venous blood
Mammary LPL liberates FFA
Note that mammary LPL is high independent of I
Glut 4
Glut 1
Optimising Lactogenesis
Gene Significance Possible role in udder
LALBA P<0.01 Alpha-lactalbumin. Involved in lactose synthesis
and plays a key role in determining milk volume
VEGF P<0.01 Vascular endothelial growth factor. Promotes
angiogenesis
VEGFR1 P<0.001 Receptor for VEGF
VEGFR2 P=0.001 Receptor for VEGF
ANGPT2 P<0.01 Angiopoietin 2, promotes angiogenesis in
conjunction with VEGF
RTK P=0.001 Tyrosine kinase type 2 receptor, receptor for
ANGPT1 and ANGPT2
TGFB1R1 P=0.001 Receptor for TGFB, which is an anti-
proliferative factor for mammary cells
TGFB1R2 P<0.001 Receptor for TGFB
IGFBP5 P<0.001 Binding protein that prevents the cell-survival
activity of IGF1, hence regarded as pro-apoptotic
in mammary tissue
TBXAS1 P=0.001 Thromboxane-A synthase 1, catalyzes the
conversion of prostaglandin to the
vasoconstrictor, thromboxane
• Lactogenesis is not normally problematic in dairy cows, BUT:
• New evidence indicates that ANGIOGENESIS is a late event that we do not yet understand
• Question: could improved angiogensis prevent postpartum apoptosis?
• And….
Table. Developmentally-regulated genes with highest expression in early lactation
5 5
5
5 5
5 5 5
5 5 5
5 5 5
5 5 5
5
5 5
5 5 5
5
5 5
5
5
5
5 5
5 5 5
5 5
5 5 5
5
Non-lactating cow
Lactating cow
15 litre
30 litre
5 litre
125 litre
30 litre
Water Flux
Aquaporins: water channels
AQP1 (CHIP28) expressed in Xenopus laevis oocyte (right) After Agre and Parker, 1991
The "hourglass" AQP structure. Symmetrical repeats of 3 membrane spanning domains fold such that conserved NPA motifs form a neutral central pore
Mammary Aquaporins
• And…
• The switch-on of water transport is not understood
• Developmental regulation supports a role for AQP1 or AQP3, cellular localisation is strongly indicative of AQP5
• Hypothesis: Water flux is mediated by AQP5, which is expressed prepartum but active postpartum
Are there AQP on the mammary Golgi membrane?
If so, are they developmentally regulated?
AQP?
AQP?
AQP?
Targets for Optimising Lactation
• Optimising Mammogenesis • Obesity, BST
• Optimising Lactogenesis • Angiogenesis, AQP, Obesity
• Optimising Milk Yield • rBST
• Optimising Persistency • Extended Lactation
• Optimising Animal Health • bST and cow health
• How are you, cow?
rBST in the US dairy industry
BST stands for bovine somatotrophin
Somatotrophin is US for growth hormone (GH)
GH was first described more than 70 years ago
Effects on lactation were noted in rats, then in cows as long ago as 1937
Pituitary extracts containing GH were extensively researched as lactation enhancers in 1940s
BST: Background and History
BST was produced using recombinant DNA technology in the early 1980s
Several companies competed to produce the first viable product
First rBST study in dairy cows in 1982
By 1992 there were >1000 studies in >40,000 cows
>1,500 publications since 1993
rBST
Bauman et al, 1985 J Dairy Sci. 68, 1352-1362
What it does
+ BST
Repartitions nutrients towards udder
Causes mobilisation initially…
…then increased intake
Homeorhetic
How it does it
Energy Balance
Cows do NOT get thin!
They may even get too fat!
BST approved for use in >25 countries Posilac (Monsanto) gained US approval in Nov
1993 Was sold in US by Protiva starting Feb 1994 Initially made in Austria Since march 2006 produced in Georgia, USA Was licensed to Elanco outwith US Freely available to US farmers without
prescription 2008: Posilac product sold to Elanco
Commercial Product
500mg zinc methionyl BST
Pre-packed syringe
Administered by i.m. injection
Given once every two weeks
Starting after 60d postpartum Standard management for high-yield cow
Do not use within 2wk of slaughter
The Product
Pre-C Post-C Pre-
BST
Post-
BST
Milk
kg/d
27.2 28.8 28.7 33.0
Fat
%
3.67 3.64 3.63 3.57
Prot
%
3.21 3.15 3.19 3.17
SCC 3.22 3.08 3.10 3.17
Commercial Responses
Use of BST in dairy cows is banned
Importation of dairy products produced with BST is allowed
Importation of BST is allowed
Experimental use of BST is allowed under relevant control
Current EU Position
Perceived Safety Issue
The bottom line is that this mom has come to the same conclusion as this Dr. had previously: that milk and dairy products from cows treated with rbST are safe for my children and me to consume.
Targets for Optimising Lactation
• Optimising Mammogenesis • Obesity, BST
• Optimising Lactogenesis • Angiogenesis, AQP, Obesity
• Optimising Milk Yield • rBST
• Optimising Persistency • Extended Lactation
• Optimising Animal Health • bST and cow health
• How are you, cow?
Why stop?
0 100 200 300 400 500
Days in milk
20
30
40
50
Mil
k y
ield
(k
g/d
)
Re-bred
Not re-bred
Modern cows can lactate for at least 18 months
But this is US data, with BST
BST increases lactation persistency
10 15 20 25 30 35 40
Week of lactation
4
8
12
16
Mil
k y
ield
(k
g/w
k,
sin
gle
gla
nd
)
3X + BST
BST
3X
2X
Optimum rebreeding time
Dogma: 60d
De Vries et al (2006) USA
What about Europe?
Are we missing an opportunity?
60% of vet costs are incurred in the first 45d of lactation
Stage of lactation
Mil
k y
ield
Metabolic problem sat peak lactation
Increased m astitis,lam eness
High yieldat drying-off
Calving Drying-off
Failure to rebreed
Extrem e riskperiod
Risk avoidance
Conventional lactation: 3 risk periods
Extended lactation: 2 risk periods
Milk y
ield
Autumn Autumn Autumn Autumn
Milk y
ield
Autumn Autumn Autumn Autumn
Persistency must be improved
So what is extended lactation?
• Delayed rebreeding
Combined with….
• Management for increased persistency
Strategies for improving persistency
Breed for increased persistency
Identify the persistent cow, delay re-breeding
Manage the whole herd for increased persistency
Managing for increased persistency without BST
Would the combination of frequent milking and more appropriate nutrition increase lactation persistency?
Lactation persistency: 9 months M
ilk y
ield
(kg
/d) Supplemented
Normal
Anovar: n.s.(P=0.07)
15
30
5 35Week
3X
2X
Anovar: P=0.03
Week5 35
Nutrition Milking Frequency
Effect of pregnancy on lactation persistency
-10 -5 0 5 10 15 20 25 30
Week of pregnancy
0
2
4
6
8
10
12
14
Half-u
dd
er
milk y
ield
(kg
/d)
Lactation persistency: 16 months
Milking frequency
5 10 15 20 25 30 35 40 45 50 55 60 65
standardised lactation week
0
5
10
15
20
25
Half-u
dd
er
milk y
ield
(kg
/d)
Thrice daily
Twice daily
A 60 week lactation could become 100 weeks
Milk quality during extended lactation
Rebreeding and health
300
400
500
600
700
Ca
lvin
g i
nte
rva
l (d
)
Control Extended
Target
Target
Actual
Actual
Reproductive problems at 9 months were different to usual 2 month problems
Outcome was similar
All of the cows remained healthy throughout two eighteen month lactations
Extended lactation: Profitability
• For 100 cows: – extra cost of
£22K
– extra revenue of £42K
– extra profit of £20K
One ‘recipe’ for extended lactation (there could be others)
• High yielding cows • Frequent robotic milking • Quality feed, year round • Bring the feed on gradually, but then keep it on • Careful attention to lactation curve • All-year-round partial housing • Re-breed:
– at 9 months – or at time dictated by lactation curve
• Partnership with vet
Targets for Optimising Lactation
• Optimising Mammogenesis • Obesity, BST
• Optimising Lactogenesis • Angiogenesis, AQP, Obesity
• Optimising Milk Yield • rBST
• Optimising Persistency • Extended Lactation
• Optimising Animal Health • bST and cow health
• How are you, cow?
rBST use: consequences for animal health and consumer safety
BST: a distressing product • CWF analysis by Joyce D’Silva
BST is a cynical abuse of both the dairy cow and the dairy farmer • Prof John Webster, Bristol Univ. Vet. School
Metabolic effects of BST
0.2 BCS units loss in entire lactation
The milk yield response is comparable to thrice-daily milking
The milk yield response is sub-maximal
The cow retains control
Incidence of mastitis and lameness
Control BST Control BST
0
10
20
30
Co
ws
aff
ec
ted
(%
)
n.s. n.s.
Heifers Cows
Control BST Control BST
0
10
20
30
n.s. P<0.001
Heifers Cows
Mastitis Lameness
Conclusions on cow health Injection site reactions are unacceptable
BST is associated with a small but measurable increase in disease incidence
Cause and effect has not been established
Irrespective of the degree and mechanism, this is unacceptable...
...as is continuous genetic improvement with no regard to better practice
Targets for Optimising Lactation
• Optimising Mammogenesis • Obesity, BST
• Optimising Lactogenesis • Angiogenesis, AQP, Obesity
• Optimising Milk Yield • rBST
• Optimising Persistency • Extended Lactation
• Optimising Animal Health • bST and cow health
• Health and Welfare Technology
Sensors for Dairy health and Welfare: The Dairy ICT Project
• In the Dairy ICT project we are developing new uses for accelerometer collars, expanding the utility of milk metabolomics and building novel biomarker technologies
• Outputs from these novel technologies will be integrated into ICT-based "smart" husbandry support systems for use by dairy farmers.
Dairy ICT Project will expand existing proven technologies
Herd Navigator: Progesterone
LDH BHB
Oestrus detection
Add SAR
A
Add lameness
Add feeding activity
Dairy ICT Project will view biomarkers differently
Dairy ICT Project will develop minimalist approaches to smart systems
Know desired state
Integrate, compare, evaluate,
Know previous
state
Know current state
Welfare biomarker
data
Accelerometer collar
data
Milk metabolomic
data
Initiate Action
Existing state of art
data
Existing state of art
data
Dairy ICT Project, Example biomarker data
Dairy ICT Project, example biomarker data
Dairy ICT Project, example activity data
Dairy ICT Project, example activity data
Dairy ICT Project, www.dairyict.eu
Thank you!
You may also be interested in the new COST Action FA1308,
DairyCare www.dairycareaction.org